PB-141 is a synthetic peptide classified as a melanocortin receptor agonist, primarily indicated for the treatment of hypoactive sexual desire disorder in premenopausal women. By activating central melanocortin… Read more








PB-141 is a synthetic peptide classified as a melanocortin receptor agonist, primarily indicated for the treatment of hypoactive sexual desire disorder in premenopausal women. By activating central melanocortin receptors to stimulate libido and arousal, this compound operates through a mechanism distinct from traditional therapies. Laboratories working with this therapeutic agent require high-quality reference standards for rigorous analytical testing and method validation. This collection includes a comprehensive range of PB-141 impurities, metabolites, and stable isotope labelled compounds essential for accurate impurity profiling and quantitative analysis. These reference materials are critical for ensuring compliance in quality control processes throughout the drug's development cycle, allowing researchers to monitor degradation products and verify assay precision during stability testing. The availability of deuterated and 13C-labelled standards supports reliable identification and quantification of the parent drug and its related substances in complex pharmaceutical matrices.